The end of 23andMe’s drug discovery dream

By STAT News
| November 15, 2024

The company is halting its efforts to develop new medicines and laying off 40% of its workforce

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...